Literature DB >> 8343758

Clozapine in the management of schizophrenia. All schizophrenic patients would benefit.

R Kerwin, F Lofts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8343758      PMCID： PMC1678327          DOI： 10.1136/bmj.307.6897.199-b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Clozapine: progress in treating refractory schizophrenia.

Authors:  S R Hirsch; B K Puri
Journal:  BMJ       Date:  1993-05-29

2.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

3.  The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years.

Authors:  L H Lindström
Journal:  Acta Psychiatr Scand       Date:  1988-05       Impact factor: 6.392
  3 in total
  1 in total

1.  Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel.

Authors:  G Ginsberg; S Shani; B Lev
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.